TNF inhibitors, corticosteroids do not impact COVID-19 vaccine efficacy for IBD patients

TNF inhibitors, corticosteroids do not impact COVID-19 vaccine efficacy for IBD patients

Among patients with inflammatory bowel disease, the effectiveness of the COVID-19 vaccine was similar when compared to controls without the disease, according to study results.“[We] found that COVID-19 BNT162b2 vaccine was equally effective in IBD patients and in the non-IBD population, including those on TNF inhibitors and corticosteroids, and likely did not increase the risk of IBD exacerbation,” Raffi Lev-Tzion, MD, of The Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition at Shaare Zedek Medical Center, The Hebrew University of Jerusalem, in Israel,Read More

Share on facebook
Share on twitter
Share on linkedin